These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22013107)

  • 1. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
    Pilz S; Kienreich K; Drechsler C; Ritz E; Fahrleitner-Pammer A; Gaksch M; Meinitzer A; März W; Pieber TR; Tomaschitz A
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health and aldosterone excess.
    Ceccoli L; Ronconi V; Giovannini L; Marcheggiani M; Turchi F; Boscaro M; Giacchetti G
    Osteoporos Int; 2013 Nov; 24(11):2801-7. PubMed ID: 23695421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting parathyroid hormone levels in different types of primary aldosteronism.
    Jiang Y; Zhang C; Ye L; Su T; Zhou W; Jiang L; Zhang Y; Wang W
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):267-74. PubMed ID: 26589237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism.
    Maniero C; Fassina A; Seccia TM; Toniato A; Iacobone M; Plebani M; De Caro R; Calò LA; Pessina AC; Rossi GP
    J Hypertens; 2012 Feb; 30(2):390-5. PubMed ID: 22179087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
    Markou A; Pappa T; Kaltsas G; Gouli A; Mitsakis K; Tsounas P; Prevoli A; Tsiavos V; Papanastasiou L; Zografos G; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1409-16. PubMed ID: 23471976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.
    Tuersun T; Luo Q; Zhang Z; Wang G; Zhang D; Wang M; Wu T; Zhou K; Yue N; Li N
    Hypertens Res; 2020 Dec; 43(12):1413-1420. PubMed ID: 32770102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L; Prisco S; Vanderriele PE; Lerco S; Torresan F; Maiolino G; Seccia TM; Iacobone M; Rossi GP
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3726-3734. PubMed ID: 30865228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid Gland Function in Primary Aldosteronism.
    Asbach E; Bekeran M; Reincke M
    Horm Metab Res; 2015 Dec; 47(13):994-9. PubMed ID: 26667802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
    Pilz S; Trummer C; Verheyen N; Schwetz V; Pandis M; Aberer F; Grübler MR; Meinitzer A; Bachmann A; Voelkl J; Alesutan I; Catena C; Sechi LA; März W; Obermayer-Pietsch B; Tomaschitz A
    Horm Metab Res; 2018 May; 50(5):375-382. PubMed ID: 29723896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone to active Renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loading.
    Pilz S; Kienreich K; Gaksch M; Grübler M; Verheyen N; Bersuch LA; Schmid J; Drechsler C; Ritz E; Moosbrugger A; Stepan V; Pieber TR; Meinitzer A; März W; Tomaschitz A
    Horm Metab Res; 2014 Jun; 46(6):427-32. PubMed ID: 24526370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
    Papanastasiou L; Markou A; Pappa T; Gouli A; Tsounas P; Fountoulakis S; Kounadi T; Tsiama V; Dasou A; Gryparis A; Samara C; Zografos G; Kaltsas G; Chrousos G; Piaditis G
    Eur J Clin Invest; 2014 Aug; 44(8):697-706. PubMed ID: 24909545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.